Article
Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
European journal of cancer (Oxford, England : 1990) - 1 Nov 2014
García-Flores María, Casanova-Salas Irene, Rubio-Briones José, Calatrava Ana, Domínguez-Escrig José, Rubio Luis, Ramírez-Backhaus Miguel, Fernández-Serra Antonio, García-Casado Zaida, López-Guerrero José Antonio
Abstract excerpt
AIMS: Speckle-type POZ protein (SPOP) is an E3 ubiquitin ligase adaptor recently described to be mutated in prostate cancer (PCa). Hence, studying the gene expression profile and the presence of SPOP mutations in PCa and understanding its clinico-pathological significance as prognostic and therapeutic biomarker are important to further understand its role in PCa development. PATIENTS AND METHODS: A cohort of 265...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
